Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Chemotherapy-Free Combination Regimen. Show all posts
Showing posts with label Chemotherapy-Free Combination Regimen. Show all posts
Friday, October 11, 2019

AbbVie Announces US FDA Approval of Venclexta (venetoclax) as a Chemotherapy-Free Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia Patients

›
In continuation of my update on  Venclexta (venetoclax) AbbVie a research-based global biopharmaceutical  company,  announced th...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.